We're here to help.
What information are you looking for?
The Alzheimer Society of Canada believes people with dementia should have a voice in the work that impacts them. We want to bring people from all over the country together to be part of the conversation by becoming a member of our Advisory Group.
When COVID-19 locked down retirement and long-term care homes across Canada, Kim Neudorf was one of many Canadians who felt concern about how the changes would affect her mother.
The Alzheimer Society of Canada is disappointed to hear that, after reviewing data from Phase 3 clinical trials, a U.S. Food and Drug Administration (FDA) advisory panel did not find conclusive evidence that a potential new treatment for Alzheimer’s was effective at reducing cognitive decline.